Top

Published in:

01-12-2019 | Educational Review

Hypertensive crisis in children and adolescents

Authors: Tomáš Seeman, Gilad Hamdani, Mark Mitsnefes

Published in: Pediatric Nephrology | Issue 12/2019

Abstract

Hypertensive crisis is a relatively rare condition in children. However, if not treated, it might be life-threatening and lead to irreversible damage of vital organs. Clinical presentation of patients with hypertensive crisis can vary from very mild (hypertensive urgency) to severe symptoms (hypertensive emergency) despite similarly high blood pressure (BP). Individualized assessment of patients presenting with high BP with emphasis on the evaluation of end-organ damage rather than on the specific BP number is a key in guiding physician’s initial management of a hypertensive crisis. The main aim of the treatment of hypertensive crisis is the prevention or treatment of life-threatening complications of hypertension-induced organ dysfunction, including neurologic, ophthalmologic, renal, and cardiac complications. While the treatment strategy must be directed toward the immediate reduction of BP to reduce the hypertensive damage to these organs, it should not be at a too fast rate to cause hypoperfusion of vital organs by an excessively rapid reduction of BP. Thus, intravenous continuous infusions rather than intravenous boluses of antihypertensive medications should be the preferable mode of initial treatment of children with hypertensive emergency.

National High Blood Pressure Education Program Working Group on High Blood Pressure in C, Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114(2 Suppl 4th Report):555–576

Flynn JT, Tullus K (2009) Severe hypertension in children and adolescents: pathophysiology and treatment. Pediatr Nephrol 24(6):1101–1112PubMed

Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM, Subcommittee on Screening and Management of High Blood Pressure in Children (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. https://doi.org/10.1542/peds.2017-1904 PubMed

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee (2003) Seventh report of the joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42(6):1206–1252PubMed

Chandar J, Zilleruelo G (2012) Hypertensive crisis in children. Pediatr Nephrol 27(5):741–751PubMed

Lurbe E, Agabiti-Rosei E, Cruickshank JK (2016) European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 34(10):1887–1920PubMed

Aronson S (2014) Perioperative hypertensive emergencies. Curr Hypertens Rep 16(7):448PubMed

Agarwal A, Kapur G, Altinok D (2015) Childhood posterior reversible encephalopathy syndrome: magnetic resonance imaging findings with emphasis on increased leptomeningeal FLAIR signal. Neuroradiol J 28(6):638–643PubMedPubMedCentral

Deal JE, Barratt TM, Dillon MJ (1992) Management of hypertensive emergencies. Arch Dis Child 67(9):1089–1092PubMedPubMedCentral

10.

McNiece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, Portman RJ (2007) Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr 150(6):640–644 644 e641PubMed

11.

Wu HP, Yang WC, Wu YK, Zhao LL, Chen CY, Fu YC (2012) Clinical significance of blood pressure ratios in hypertensive crisis in children. Arch Dis Child 97(3):200–205PubMed

12.

Lee GH, Lee IR, Park SJ, Kim JH, Oh JY, Shin JI (2016) Hypertensive crisis in children: an experience in a single tertiary care center in Korea. Clin Hypertens. https://doi.org/10.1186/s40885-016-0040-2

13.

Yang WC, Zhao LL, Chen CY, Wu YK, Chang YJ, Wu HP (2012) First-attack pediatric hypertensive crisis presenting to the pediatric emergency department. BMC Pediatr 12:200PubMedPubMedCentral

14.

Deshmukh A, Pant S, Kumar G, Murugiah K, Mehta J (2012) Seasonal variation in hypertensive emergency hospitalization. J Clin Hypertens 14(4):269–270

15.

Wang YC, Lin YK (2014) Association between temperature and emergency room visits for cardiorespiratory diseases, metabolic syndrome-related diseases, and accidents in metropolitan Taipei. PLoS One 9(6):e99599PubMedPubMedCentral

16.

Shea S, Misra D, Ehrlich MH, Field L, Francis CK (1992) Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med 327(11):776–781PubMed

17.

Tisdale JE, Huang MB, Borzak S (2004) Risk factors for hypertensive crisis: importance of out-patient blood pressure control. Fam Pract 21(4):420–424PubMed

18.

Gill DG, Mendes de Costa B, Cameron JS, Joseph MC, Ogg CS, Chantler C (1976) Analysis of 100 children with severe and persistent hypertension. Arch Dis Child 51(12):951–956PubMedPubMedCentral

19.

Still JL, Cottom D (1967) Severe hypertension in childhood. Arch Dis Child 42(221):34–39PubMedPubMedCentral

20.

Baker MD (1986) Theophylline toxicity in children. J Pediatr 109(3):538–542PubMed

21.

Calenda E, Richez F, Muraine M (2007) Acute hypertension due to phenylephrine eyedrops in a newborn. Can J Ophthalmol 42(3):486PubMed

22.

Su JA, Tang W, Rivero N, Bar-Cohen Y (2014) Prenatal exposure to methyldopa leading to hypertensive crisis and cardiac failure in a neonate. Pediatrics 133(5):e1392–e1395PubMed

23.

Armstrong EP, Malone DC (2003) The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents. Clin Ther 25(1):1–18PubMed

24.

Brody SL, Slovis CM, Wrenn KD (1990) Cocaine-related medical problems: consecutive series of 233 patients. Am J Med 88(4):325–331PubMed

25.

Drees JC, Stone JA, Wu AH (2009) Morbidity involving the hallucinogenic designer amines MDA and 2C-I. J Forensic Sci 54(6):1485–1487PubMed

26.

Kaul A, Sharma RK, Gupta A, Singh U (2010) Spectrum of hypertension in post transplant. J Assoc Physicians India 8:221–224

27.

Luke RG (1991) Pathophysiology and treatment of posttransplant hypertension. J Am Soc Nephrol 2(2 Suppl 1):S37–S44PubMed

28.

Zarifian A, Meleg-Smith S, O’Donovan R, Tesi RJ, Batuman V (1999) Cyclosporine-associated thrombotic microangiopathy in renal allografts. Kidney Int 155(6):2457–2466

29.

Robson M, Cote I, Abbs I, Koffman G, Goldsmith D (2003) Thrombotic micro-angiopathy with sirolimus-based immunosuppression: potentiation of calcineurin-inhibitor-induced endothelial damage? Am J Transplant 3(3):324–327PubMed

30.

Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM (2011) Inflammation, immunity, and hypertension. Hypertension 57(2):132–140PubMed

31.

Singh D, Akingbola O, Yosypiv I, El-Dahr S (2012) Emergency management of hypertension in children. Int J Nephrol 2012:420247PubMedPubMedCentral

32.

Fleming S (2000) Malignant hypertension—the role of the paracrine renin-angiotensin system. J Pathol 192(2):135–139PubMed

33.

Karabacak M, Dogan A, Turkdogan AK, Kapci M, Duman A, Akpinar O (2014) Mean platelet volume is increased in patients with hypertensive crises. Platelets 25(6):423–426PubMed

34.

Zhang B, Xing C, Yu X, Sun B, Zhao X, Qian J (2008) Renal thrombotic microangiopathies induced by severe hypertension. Hypertens Res 31(3):479–483PubMed

35.

Kitiyakara C, Guzman NJ (1998) Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol 9(1):133–142PubMed

36.

Varon J, Marik PE (2003) Clinical review: the management of hypertensive crises. Crit Care 7(5):374–384PubMedPubMedCentral

37.

Vaughan CJ, Delanty N (2000) Hypertensive emergencies. Lancet 356(9227):411–417PubMed

38.

Blumenfeld JD, Laragh JH (2001) Management of hypertensive crises: the scientific basis for treatment decisions. Am J Hypertens 14(11 Pt 1):1154–1167PubMed

39.

Funakoshi Y, Ichiki T, Ito K, Takeshita A (1999) Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells. Hypertension 34(1):118–125PubMed

40.

Han Y, Runge MS, Brasier AR (1999) Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. Circ Res 84(6):695–703PubMed

41.

Ruiz-Ortega M, Lorenzo O, Ruperez M, Konig S, Wittig B, Egido J (2000) Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. Circ Res 6(12):1266–1272

42.

Collidge TA, Lammie GA, Fleming S, Mullins JJ (2004) The role of the renin-angiotensin system in malignant vascular injury affecting the systemic and cerebral circulations. Prog Biophys Mol Biol 84(2–3):301–319PubMed

43.

Nakayama I, Kawahara Y, Tsuda T, Okuda M, Yokoyama M (1994) Angiotensin II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells. J Biol Chem 269(15):11628–11633PubMed

44.

Lee MA, Bohm M, Kim S, Bachmann S, Bachmann J, Bader M, Ganten D (1995) Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rat. Hypertension 25(4 Pt 1):570–580PubMed

45.

Montgomery HE, Kiernan LA, Whitworth CE, Fleming S, Unger T, Gohlke P, Mullins JJ, McEwan JR (1998) Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27. J Hypertens 16(5):635–643PubMed

46.

Muller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A, Theuer J (2000) NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 35(1 Pt 2):193–201PubMed

47.

Mazak I, Fiebeler A, Muller DN, Park JK, Shagdarsuren E, Lindschau C, Dechend R, Viedt C, Pilz B, Haller H, Luft FC (2004) Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation 109(22):2792–2800PubMed

48.

Lassegue B, Griendling KK (2004) Reactive oxygen species in hypertension; an update. Am J Hypertens 17(9):852–860PubMed

49.

Touyz RM (2004) Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44(3):248–252PubMed

50.

Park JB, Touyz RM, Chen X, Schiffrin EL (2002) Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. Am J Hypertens 15(1 Pt 1):78–84PubMed

51.

Lip GY, Edmunds E, Nuttall SL, Landray MJ, Blann AD, Beevers DG (2002) Oxidative stress in malignant and non-malignant phase hypertension. J Hum Hypertens 16(5):333–336PubMed

52.

Endemann DH, Schiffrin EL (2004) Endothelial dysfunction. J Am Soc Nephrol 15(8):1983–1992PubMed

53.

Sato K, Kinoshita M, Kojima M, Miyagawa K, Takase H, Suzuki S, Dohi Y (2000) Failure of L-arginine to induce hypotension in patients with a history of accelerated-malignant hypertension. J Hum Hypertens 14(8):485–488PubMed

54.

Lip GY, Edmunds E, Hee FL, Blann AD, Beevers DG (2001) A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension. Am J Hypertens 14(8 Pt 1):823–828PubMed

55.

Schwartz RB, Feske SK, Polak JF, DeGirolami U, Iaia A, Beckner KM, Bravo SM, Klufas RA, Chai RY, Repke JT (2000) Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 217(2):371–376PubMed

56.

Derhaschnig U, Testori C, Riedmueller E, Aschauer S, Wolzt M, Jilma B (2013) Hypertensive emergencies are associated with elevated markers of inflammation, coagulation, platelet activation and fibrinolysis. J Hum Hypertens 27(6):368–373PubMed

57.

Al Bannay R, Bohm M, Husain A (2013) Heart rate differentiates urgency and emergency in hypertensive crisis. Clin Res Cardiol 102(8):593–598PubMed

58.

Karabacak M, Yigit M, Turkdogan KA, Yigit E, Selek S (2015) Is signal peptide-CUB-EGF domain-containing protein1 a diagnostic biomarker in patients with hypertensive crises. Clin Hemorheol Microcirc 61(3):513–522PubMed

59.

Jorg R, Milani GP, Simonetti GD, Bianchetti MG, Simonetti BG (2013) Peripheral facial nerve palsy in severe systemic hypertension: a systematic review. Am J Hypertens 26(3):351–356PubMed

60.

Ahn CH, Han SA, Kong YH, Kim SJ (2017) Clinical characteristics of hypertensive encephalopathy in pediatric patients. Korean J Pediatr 60(8):266–271PubMedPubMedCentral

61.

Kwon S, Koo J, Lee S (2001) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 24(5):361–364PubMed

62.

Stevens CJ, Heran MK (2012) The many faces of posterior reversible encephalopathy syndrome. Br J Radiol 85(1020):1566–1575PubMedPubMedCentral

63.

Lee VH, Wijdicks EF, Manno EM, Rabinstein AA (2008) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 65(2):205–210PubMed

64.

Onder AM, Lopez R, Teomete U, Francoeur D, Bhatia R, Knowbi O, Hizaji R, Chandar J, Abitbol C, Zilleruelo G (2007) Posterior reversible encephalopathy syndrome in the pediatric renal population. Pediatr Nephrol 22(11):1921–1929PubMed

65.

Gera DN, Patil SB, Iyer A, Kute VB, Gandhi S, Kumar D, Trivedi HL (2014) Posterior reversible encephalopathy syndrome in children with kidney disease. Indian J Nephrol 24(1):28–34PubMedPubMedCentral

66.

Gardner CJ, Lee K (2007) Hyperperfusion syndromes: insight into the pathophysiology and treatment of hypertensive encephalopathy. CNS Spectr 12(1):35–42PubMed

67.

Kahana A, Rowley HA, Weinstein JM (2005) Cortical blindness: clinical and radiologic findings in reversible posterior leukoencephalopathy syndrome: case report and review of the literature. Ophthalmology 112(2):e7–e11PubMed

68.

Kandt RS, Caoili AQ, Lorentz WB, Elster AD (1995) Hypertensive encephalopathy in children: neuroimaging and treatment. J Child Neurol 10(3):236–239PubMed

69.

Lin KL, Hsu WC, Wang HS, Lui TN (2006) Hypertension-induced cerebellar encephalopathy and hydrocephalus in a male. Pediatr Neurol 34(1):72–75PubMed

70.

Sanford EF, Stein JC (2012) Hypertensive encephalopathy presenting as status epilepticus in a three year old. J Emerg Med 42(6):e141–e145PubMed

71.

Logan P, Eustace P, Robinson R (1992) Hypertensive retinopathy: a cause of decreased visual acuity in children. J Pediatr Ophthalmol Strabismus 29(5):287–289PubMed

72.

Henderson AD, Biousse V, Newman NJ, Lamirel C, Wright DW, Bruce BB (2012) Grade III or grade IV hypertensive retinopathy with severely elevated blood pressure. West J Emerg Med 13(6):529–534PubMedPubMedCentral

73.

Williams KM, Shah AN, Morrison D, Sinha MD (2013) Hypertensive retinopathy in severely hypertensive children: demographic, clinical, and ophthalmoscopic findings from a 30-year British cohort. J Pediatr Ophthalmol Strabismus 50(4):222–228PubMed

74.

Kovalski Y, Cleper R, Krause I, Dekel B, Belenky A, Davidovits M (2012) Hyponatremic hypertensive syndrome in pediatric patients: is it really so rare? Pediatr Nephrol 27(6):1037–1040PubMed

75.

Mukherjee D, Sinha R, Akhtar MS, Saha AS (2017) Hyponatremic hypertensive syndrome—a retrospective cohort study. World J Nephrol 6(1):41–44PubMedPubMedCentral

76.

Dionne JM, Flynn JT (2017) Management of severe hypertension in the newborn. Arch Dis Child 102(12):1176–1179PubMed

77.

Adelman RD (1978) Neonatal hypertension. Pediatr Clin N Am 25(1):99–110

78.

Kovacikova L, Kunovsky P, Skrak P, Haviar D, Martanovic P (2005) Renovascular hypertension in infant presenting with cardiogenic shock. Pediatr Emerg Care 21(5):322–324PubMed

79.

Xiao N, Tandon A, Goldstein S, Lorts A (2013) Cardiogenic shock as the initial presentation of neonatal systemic hypertension. J Neonatal-Perinatal Med 6(3):267–272PubMed

80.

Belsh CW (2013) Management of hypertensive emergencies. In: Flynn JT, Ingelfinger JR, Portman RJ (eds) Pediatric hypertension. Humana Press, New York, pp 557–571

81.

Adelman RD, Coppo R, Dillon MJ (2000) The emergency management of severe hypertension. Pediatr Nephrol 14:422–427PubMed

82.

Patel HR, Mitsnefes MM (2005) Advances in the pathogenesis and management of hypertensive crisis. Curr Opin Pediatr 17:210–214PubMed

83.

Vaughan CJ, Delanty N (2001) Hypertensive emergencies. Lancet 56:411–417

84.

Gordillo-Paniagua G, Velásquez-Jones L, Martini R, Valdez-Bolaños E (1975) Sodium nitroprusside treatment of severe arterial hypertension in children. J Pediatr 87:799–802PubMed

85.

Webb TN, Shatat IF, Miyashita Y (2014) Therapy of acute hypertension in hospitalized children and adolescents. Curr Hypertens Rep 16:425PubMedPubMedCentral

86.

McCrory WW, Kohaut EC, Lewy JE, Lieberman E, Travis LB (1979) Safety of intravenous diazoxide in children with severe hypertension. Clin Pediatr 18:661–663 666–667, 671

87.

Rodriguez MA, Kumar SK, De Caro M (2010) Hypertensive crisis. Cardiol Rev 18:102–107PubMed

88.

Flynn JT, Mottes TA, Brophy PD, Kershaw DB, Smoyer WE, Bunchman TE (2001) Intravenous nicardipine for treatment of severe hypertension in children. J Pediatr 139:38–43PubMed

89.

Michael J, Groshong T, Tobias JD (1998) Nicardipine for hypertensive emergencies in children with renal disease. Pediatr Nephrol 12:40–42PubMed

90.

Thomas CA, Moffett BS, Wagner JL, Mott AR, Feig DI (2001) Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children. Pediatr Crit Care Med 12:28–32

91.

Schöber JG, Pilossoff W, Bühlmeyer K (1984) Urapidil therapy for acute hypertensive crises in infants and children. Eur J Pediatr 143:87–91PubMed

92.

Pio L, Avanzini S, Mattioli G, Martucciello G, Sementa AR, Conte M, Gigliotti A, Granata C, Leva E, Fagnani AM, Caccioppoli U, Tedesco N, Schleef J, Tirtei E, Siracusa F, D'Angelo P, Lelli Chiesa P, Miglionico L, Noccioli B, Severi E, Carlini C, Vaccarella F, Camoglio F, Cesaro S, Narciso A, Riccipetitoni G, Cecchetto G, Inserra A (2017) Perioperative management of hypertensive neuroblastoma: a study from the Italian Group of Pediatric Surgical Oncologists (GICOP). J Pediatr Surg 52:1633–1636PubMed

93.

Tabbutt S, Nicolson SC, Adamson PC, Zhang X, Hoffman ML, Wells W, Backer CL, McGowan FX, Tweddell JS, Bokesch P, Schreiner M (2008) The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial. J Thorac Cardiovasc Surg 136:321–328PubMed

94.

Sica DA (2007) Centrally acting antihypertensive agents: an update. J Clin Hypertens 9:399–405

95.

Hammer GB, Verghese ST, Drover DR, Yaster M, Tobin JR (2008) pharmacokinetics and pharmacodynamics of fenoldopam mesylate for blood pressure control in pediatric patients. BMC Anesthesiol 8:6PubMedPubMedCentral

96.

Wells TG, Bunchman TE, Kearns GL (1990) Treatment of neonatal hypertension with enalaprilat. J Pediatr 117:664–667PubMed

97.

Rouine-Rapp K, Mello DM, Hanley FL, Mohan Reddy V, Soifer S (2003) Effect of enalaprilat on postoperative hypertension after surgical repair of coarctation of the aorta. Pediatr Crit Care Med 4:327–332PubMed

98.

Blaszak RT, Savage JA, Ellis EN (2001) The use of short-acting nifedipine in pediatric patients with hypertension. J Pediatr 139:34–37PubMed

99.

Miyashita Y, Peterson D, Rees JM, Flynn JT (2010) Isradipine for treatment of acute hypertension in hospitalized children and adolescents. J Clin Hypertens 12:850–855

100.

Sinaiko AR, Kashtan CE, Mirkin BL (1986) Antihypertensive drug therapy with captopril in children and adolescents. Clin Exp Hypertens 8:829–839

101.

Joynt KE, Moslehi JJ, Baughman KL (2009) Paragangliomas: etiology, presentation, and management. Cardiol Rev 17:159–164PubMed

102.

Pennisi AJ, Takahashi M, Bernstein BH, Singsen BH, Uittenbogaart C, Ettenger RB, Malekzadeh MH, Hanson V, Fine RN (1977) Minoxidil therapy in children with severe hypertension. J Pediatr 90:813–819PubMed

103.

Strife CF, Quinlan M, Waldo FB, Fryer CJ, Jackson EC, Welch TR, McEnery PT, West CD (1986) Minoxidil for control of acute blood pressure elevation in chronically hypertensive children. Pediatrics 78:861–865PubMed

104.

Wiest DB, Garner SS, Uber WE, Sade RM (1998) Esmolol for the management of pediatric hypertension after cardiac operations. J Thorac Cardiovasc Surg 115:890–897PubMed

105.

Ku LC, Zimmerman K, Benjamin DK, Clark RH, Hornik CP, Smith PB, Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee (2017) Safety of enalapril in infants admitted to the neonatal intensive care unit. Pediatr Cardiol 38:155–161PubMed

106.

Saland JM, Mahony L, Baum M (2001) Perinatal renal ischemia resulting in hypertensive cardiomyopathy. Pediatrics 107:185–186PubMed

107.

Plumer LB, Kaplan GW, Mendoza SA (1976) Hypertension in infants—a complication of umbilical arterial catheterization. J Pediatr 89:802–805PubMed

108.

Ljungqvist A, Wallgren G (1962) Unilateral renal artery stenosis and fatal arterial hypertension in a newborn infant. Acta Paediatr 51:575–584PubMed

Title: Hypertensive crisis in children and adolescents
Authors: Tomáš Seeman
Gilad Hamdani
Mark Mitsnefes
Publication date: 01-12-2019
Publisher: Springer Berlin Heidelberg
Published in: Pediatric Nephrology / Issue 12/2019
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-018-4092-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Hypertensive crisis in children and adolescents

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2019

Vitamin D and cardiovascular disease in chronic kidney disease

Subclinical myocardial disease in patients with primary hyperoxaluria and preserved left ventricular ejection fraction: a two-dimensional speckle-tracking imaging study

An adolescent with lupus nephritis presenting with fever, lymphadenomegaly, and arthralgia: Questions

Defining a threshold for tacrolimus intra-patient variability associated with late acute cellular rejection in paediatric kidney transplant recipients

Prevalence and outcomes of fragility: a frailty-inflammation phenotype in children with chronic kidney disease

Does MEST-C score predict outcomes in pediatric Henoch-Schönlein purpura nephritis?